Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2007;49:178-184
Published online before print November 13, 2006, doi: 10.1161/01.HYP.0000251360.40838.0f
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
49/1/178    most recent
01.HYP.0000251360.40838.0fv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Takeda, K.
Right arrow Articles by Fong, G.-H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Takeda, K.
Right arrow Articles by Fong, G.-H.
Related Collections
Right arrow Angiogenesis
Right arrow Endothelium/vascular type/nitric oxide
Right arrow Other Vascular biology

(Hypertension. 2007;49:178.)
© 2007 American Heart Association, Inc.


Original Articles

Prolyl Hydroxylase Domain 2 Protein Suppresses Hypoxia-Induced Endothelial Cell Proliferation

Kotaro Takeda; Guo-Hua Fong

From the Center for Vascular Biology, Department of Cell Biology, University of Connecticut Health Center, Farmington.

Correspondence to Guo-Hua Fong, Center for Vascular Biology, University of Connecticut Health Center, 263 Farmington Ave, Farmington, CT 06030-3501. E-mail fong{at}nso2.uchc.edu

Prolyl hydroxylase domain 2 protein (PHD2) signals the degradation of hypoxia-inducible factor (HIF)-1{alpha} by hydroxylating specific prolyl residues located within oxygen-dependent degradation domains. As expected, endothelial cells (ECs) overexpressing PHD2 had reduced HIF-1{alpha} and vascular endothelial growth factor-A expression and failed to accelerate their proliferation in response to hypoxia. Surprisingly, although these cells displayed further reductions in HIF-1{alpha} and vascular endothelial growth factor-A expression when cultured under normoxia, there was no further reduction in EC proliferation. Thus, there seemed to be no consistent correlation between PHD2 hydroxylase–mediated suppression of HIF-1{alpha} expression and inhibition of EC growth. Indeed, overexpression of a mutant PHD2 lacking hydroxylase activity also greatly diminished EC response to hypoxia-induced increase in proliferation, in spite of the fact that hypoxia-induced HIF-1{alpha} accumulation was not affected by mutant PHD2. These data strongly suggest the existence of a hydroxylase-independent mechanism for PHD2-mediated inhibition of EC proliferation under hypoxia. In support of a physiological relevance of PHD2 overexpression, we found that endogenous PHD2 expression was significantly upregulated by hypoxia and that silencing of the Phd2 gene by RNA interference significantly enhanced hypoxia-induced EC proliferation. In conclusion, this study demonstrates that PHD2 may act as a negative feedback regulator to antagonize hypoxia-induced EC proliferation.


Key Words: prolyl hydroxylase domain 2 protein • hypoxia-inducible factor • vascular endothelial growth factor • vascular endothelial cells and cell proliferation




This article has been cited by other articles:


Home page
GeneticsHome page
Z. Shao, Y. Zhang, and J. A. Powell-Coffman
Two Distinct Roles for EGL-9 in the Regulation of HIF-1-Mediated Gene Expression in Caenorhabditis elegans
Genetics, November 1, 2009; 183(3): 821 - 829.
[Abstract] [Full Text] [PDF]